Shopping Cart
Remove All
Your shopping cart is currently empty
AG-1478
Copy Product Info
😃Good
Catalog No. T2047Cas No. 153436-53-4
Alias Tyrphostin AG-1478, NSC 693255, AG1478
AG-1478 (NSC-693255) (Tyrphostin AG-1478) is a selective EGFR inhibitor.
AG-1478
Copy Product Info😃Good
Purity: 99.71%
Catalog No. T2047Alias Tyrphostin AG-1478, NSC 693255, AG1478Cas No. 153436-53-4
AG-1478 (NSC-693255) (Tyrphostin AG-1478) is a selective EGFR inhibitor.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $45 | In Stock | In Stock | |
| 10 mg | $61 | In Stock | In Stock | |
| 25 mg | $114 | In Stock | In Stock | |
| 50 mg | $207 | In Stock | In Stock | |
| 100 mg | $288 | In Stock | In Stock | |
| 200 mg | $374 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $50 | In Stock | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.71%
Color:White to Yellow
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | AG-1478 (NSC-693255) (Tyrphostin AG-1478) is a selective EGFR inhibitor. |
| Targets&IC50 | EGFR:3 nM |
| In vitro | Co-administration of 0.4 mg AG-1478 with a single dose of 25 μCi 90Y-CHX-A''-DTPA-hu3S193 results in significantly enhanced potency compared to the drugs administered separately. AG-1478 blocks phosphorylation of EGFR at tumor sites and inhibits growth in xenograft models of A431 cells overexpressing wt EGFR and glioma expressing de2-7 EGFR. Even subtherapeutic doses of AG-1478 significantly increase the potency of cytotoxic drugs. The combination of AG-1478 and temozolomide shows synergistic antitumor activity against human glioma xenografts. |
| In vivo | At a concentration of 0.25 μM, AG-1478 effectively inhibits Ang II, Ca2+ ionophore, and EGF-induced MAPK activation in VSMCs, without affecting fosinopril or platelet-derived growth factor-BB (PDGF-BB)-induced MAPK activation. AG-1478 also suppresses EGF-induced mitosis in BaF/ERX and LIM1215 cells, with IC50 values of 0.07 μM and 0.2 μM, respectively. Furthermore, AG-1478 inhibits the function of ABC (ATP-binding cassette) transport proteins, such as ABCB1 and ABCG2, showing a more significant effect on ABCG2. In comparison to cells expressing endogenous wild-type EGFR or overexpressing exogenous wild-type EGFR (with IC50 values of 34.6 μM and 48.4 μM respectively), AG-1478 preferentially inhibits U87 mg cells expressing ΔEGFR, with an IC50 of 8.7 μM. It also preferentially inhibits tyrosine kinase activity and autophosphorylation of ΔEGFR over endogenous or overexpressed exogenous wild-type EGFR. |
| Cell Research | Cells are exposed to different concentrations of AG-1478 for 72 hours in 96-well plates. The effects of AG-1478 on cell growth are examined using an Alamar Blue assay. A 20-μL aliquot of Alamar Blue is added to each well, and its absorbance is determined using a Spectromax Scanning Micro plate Reader. The effects of AG-1478 are expressed as percentage of growth inhibition using untreated cells as the control (0% inhibition). Cellular DNA synthesis is determined using a [3H]thymidine incorporation assay. (Only for Reference) |
| Synonyms | Tyrphostin AG-1478, NSC 693255, AG1478 |
| Molecular Weight | 315.75 |
| Formula | C16H14ClN3O2 |
| Cas No. | 153436-53-4 |
| Smiles | N(C=1C2=C(C=C(OC)C(OC)=C2)N=CN1)C3=CC(Cl)=CC=C3 |
| Relative Density. | 1.337g/cm3 |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | Ethanol: < 1 mg/mL (insoluble or slightly soluble)  H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 10 mg/mL (31.67 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (3.17 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
virusTyrphostin AG1478Tyrphostin AG 1478PDGFRobesityNSC-693255NSC693255myocardialinjuryInhibitorinhibitInfluenzaVirusInfluenza VirusHER2HER1Hepatitis C virusHCVProteaseHCV ProteaseHCVErbB-1Epidermal growth factor receptorencephalomyocarditisEMCVEGFRdiseaseschemotherapycardiovascularcancerantiviralAG-1478AG 1478
Preview
Related Tags: buy AG-1478 | purchase AG-1478 | AG-1478 cost | order AG-1478 | AG-1478 chemical structure | AG-1478 in vivo | AG-1478 in vitro | AG-1478 formula | AG-1478 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.